KaliVir Immunotherapeutics
Lyka Mamaril has three years of work experience, beginning in 2019. Lyka was a Pharmacy Technician Trainee at Giant Eagle, Inc. from 2019 to 2022. During this time, they were also an Undergraduate Research Assistant in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh, a Student Worker in the Palladino Laboratory, and a Summer Research Student. In 2022, they began working as a QC Laboratory Technician at KaliVir Immunotherapeutics.
Lyka Mamaril attended Duquesne University from 2018 to 2019 and studied Pre-Pharmacy Studies. Lyka then attended the University of Pittsburgh from 2019 to 2022, where they earned a Bachelor of Science in Biochemistry and Molecular Biology.
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells